Table 1.
Studies Demonstrating Disparities in NAFLD Prevalence
| Author/Year | Study Design | Method of NAFLD Diagnosis | NAFLD Prevalence, n (%) | |||||
|---|---|---|---|---|---|---|---|---|
| Overall | White | Black | Hispanic | Asian | Other | |||
| Weston et al. (2005) 8 | Cross‐sectional | Imaging (ultrasound, CT) | 159 (21.4) | 71 (N/A) | 5 (N/A) | 45 (N/A) | 28 (N/A) | 10 (N/A) |
| Laboratory tests | ||||||||
| Biopsy | ||||||||
| Lazo et al. (2013) 40 | Cross‐sectional | Imaging (ultrasound) | 2366 (19) | 421 (17.8) | 319 (13.5) | 570 (24.1) | N/A | N/A |
| Wagenknecht et al. (2009) 9 | Cross‐sectional | Imaging (CT) Laboratory tests | 224 (19.6) | N/A | 22 (10) | 54 (24) | N/A | N/A |
| Glucose tolerance | ||||||||
| Trico et al. (2018) 10 | Cohort | Imaging (MRI) Genotyping | 209 (41.6) | 82 (42.9) | 21 (15.7) | 106 (59.6) | N/A | N/A |
| Glucose tolerance | ||||||||
| Patel et al. (2018) 41 | Retrospective | Biopsy | 76 (19.0) | 55 (N/A) | 9 (N/A) | 4 (N/A) | 2 (N/A) | 6 (N/A) |
| Case‐control | ||||||||
| Mohanty et al. (2009) 11 | Cross‐sectional | Imaging | 238 (34.8) | 154 (N/A) | 36 (N/A) | 32 (N/A) | 16 (N/A) | N/A |
| Laboratory tests | ||||||||
| Biopsy | ||||||||
| Birerdinc et al. (2012) 42 | Cross‐sectional | Laboratory tests (aminotransferases) | 1782 (9.6) | 1247 (14.0) | 131 (6.4) | 314 (14.0) | N/A | N/A |
| Browning et al. (2004) 43 | Cross‐sectional | Imaging (MRI) | 687 (30.7) | 242 (33.0) | 265 (24.0) | 180 (44.9) | N/A | N/A |
| Kim et al. (2013) 44 | Cross‐sectional | Imaging (ultrasound) | 94 (28.3) | 47 (36.2) | 47 (23.4) | N/A | N/A | N/A |
| Loomba et al. (2015) 45 | Cross‐sectional | Imaging (MRI) | 26 (21.7) | 18 (19.1) | N/A | 5 (27.8) | N/A | N/A |
| North et al. (2012) 46 | Cross‐sectional | Imaging (CT) | 181 (6.6) | 159 (7.2) | 22 (4.3) | N/A | N/A | N/A |
| Reddy et al. (2013) 47 | Cross‐sectional | ICD‐9 codes | 32,347 (10.7) | 20536 (11.8) | 2798 (5.8) | 4135 (11.4) | N/A | N/A |
| Tison et al. (2015) 48 | Cross‐sectional | Imaging (CT) | 706 (17.3) | 229 (15.2) | 138 (11.2) | 259 (27.1) | N/A | N/A |
| Williams et al. (2011) 49 | Cross‐sectional | Imaging (ultrasound) | 151 (46.0) | 91 (44.4) | 13 (35.1) | 42 (58.3) | N/A | N/A |
| Biopsy | ||||||||
| Younossi et al. (2012) 50 | Cross‐sectional | Imaging (ultrasound) | 2492 (21.5) | 1885 (12.2) | 211 (6.6) | 190 (12.6) | N/A | N/A |
| Laboratory tests (aminotransferases) | ||||||||